Source: EURLEX
Language: en
Format: md

|  |  |  |  |
| --- | --- | --- | --- |
| 19.2.2018 | EN | Official Journal of the European Union | C 63/13 |

---

Action brought on 28 November 2017 — Medora Therapeutics v EUIPO — Biohealth Italia (LITHOREN)

(Case T-776/17)

(2018/C 063/18)

Language in which the application was lodged: English

Parties

Applicant: Medora Therapeutics LTD (Halandri, Greece) (represented by: S. Santos Rodríguez, lawyer)

Defendant: European Union Intellectual Property Office (EUIPO)

Other party to the proceedings before the Board of Appeal: Biohealth Italia Srl (Rivoli, Italy)

Details of the proceedings before EUIPO

Proprietor of the trade mark at issue: Applicant

Trade mark at issue: EU word mark ‘LITHOREN’ — EU trade mark No 12 744 901

Procedure before EUIPO: Proceedings for a declaration of invalidity

Contested decision: Decision of the Second Board of Appeal of EUIPO of 14 September 2017 in Case R 178/2017-2

Form of order sought

The applicant claims that the Court should:

|  |  |
| --- | --- |
| — | annul the contested decision; |

|  |  |
| --- | --- |
| — | order EUIPO to pay the costs, including those incurred in the proceedings before EUIPO. |

Pleas in law

|  |  |
| --- | --- |
| — | Infringement of Article 53(1)(a) of Regulation No 207/2009; |

|  |  |
| --- | --- |
| — | Infringement of Article 8(1)(b) of Regulation No 207/2009. |

---

[Top](#document1)